Abstract
The generalized semiparametric mixed varying-coefficient effects model for longitudinal data can accommodate a variety of link functions and flexibly model different types of covariate effects, including time-constant, time-varying, and covariate-varying effects. The time-varying effects are unspecified functions of time and the covariate-varying effects are nonparametric functions of a possibly time-dependent exposure variable. A semiparametric estimation procedure is developed that uses local linear smoothing and profile weighted least squares, which requires smoothing in the two different and yet connected domains of time and the time-dependent exposure variable. The asymptotic properties of the estimators of both nonparametric and parametric effects are investigated. In addition, hypothesis testing procedures are developed to examine the covariate effects. The finite-sample properties of the proposed estimators and testing procedures are examined through simulations, indicating satisfactory performances. The proposed methods are applied to analyze the ACTG 244 clinical trial to investigate the effects of antiretroviral treatment switching in HIV-infected patients before and after developing the T215Y antiretroviral drug resistance mutation.
Keywords: Link function, local linear smoothing, profile weighted least squares, testing covariate-varying effects, varying-coefficient effects
Résumé:
Insérer votre résumé ici. We will supply a French abstract for those authors who can’t prepare it themselves. La revue canadienne de statistique : 1–25; 2011
1. INTRODUCTION
Varying-coefficient models for cross-sectional data have been extensively studied (e.g., Hastie & Tibshirani, 1993; Yin et al., 2008). Research on varying-coefficient models for longitudinal data has mostly focused on time-varying effect models; see Martinussen & Scheike (2001), Lin & Ying (2001), Wu & Liang (2004), Fan & Li (2004), Hu et al. (2004), Qu & Li (2006), Fan et al. (2007), & Sun et al. (2013), among others. Semiparametric time-varying coefficient models specify some covariate effects to be time-constant and allow others to vary with time. Although time-varying coefficient models have attractive properties, in many applications certain covariate effects (e.g., treatment effects) may vary with an exposure variable.
The AIDS Clinical Trial Group (ACTG) 244 trial illustrates an application of the semiparametric covariate-varying coefficient model. ACTG 244 adaptively randomized HIV-infected patients to different antiretroviral regimens based on the occurrence of a drug resistance mutation, and the antiretroviral treatment effects on longitudinal markers of HIV disease progression may vary with time since treatment randomization/switching.
We now use this example to illustrate the newly proposed methods. ACTG 244 enrolled HIV-infected patients taking zidovudine (ZDV) monotherapy and monitored their HIV in plasma every eight weeks for presence of the T215Y/F ZDV resistance mutation (Principi et al., 1994; Japour et al., 1995). Upon detection of the 215 mutation in a participant’s plasma, she or he was randomized to either continue ZDV or to switch to ZDV plus didanosine (ddI) or ZDV plus ddI plus nevirapine (NVP). The primary objective of ACTG 244 was to assess how an adaptive treatment randomization affected longitudinal measurements of CD4 cell counts and plasma HIV viral loads (Qi et al., 2017). The newly developed methods can be applied to examine the possible time-varying effects of adaptive treatment randomization or switching (Chen, 2013). As such, the treatment randomization/switching constitutes a covariate-varying covariate effect with the exposure modifying variable the time since treatment randomization/switching. The methods can also be applied to study the nonlinear interactions between dose intensity and other covariates (Yin et al., 2008). In addition, the proposed methods can be applied generally to clinical settings where patients switched therapies based on the monitoring of a biomarker (Gilks et al., 2006; Phillips et al., 2008).
For these applications, we investigate the generalized semiparametric model with mixed covariate-varying effects for longitudinal data with a general link function. The ability to select from different link functions provides a rich family of models for longitudinal data, including categorical response data where little work has been done. Furthermore, the proposed methods do not assume any specific model for the sampling times, which accommodates the among-participant heterogeneity of study visits without risking assumptions that may be false.
A major contribution here is the nonparametric modeling of the possibly time-dependent covariate-varying effects. Qi et al. (2017) recently studied these longitudinal models with covariate-varying covariate effects. However, these models specified a parametric form for the covariate-varying effects, therefore at risk of model misspecifications. The new approach lets data speak and provides greater flexibility and robustness in modeling both time-dependent and covariate-varying effects. This new approach requires a substantially different and more challenging theoretical development. Another major contribution is the development of the hypothesis testing procedures to examine the covariate-varying effects and their monotonicity, which, to the best of our knowledge, have not been studied before.
The remainder of the article is organized as follows. We introduce the generalized semiparametric varying-coefficient regression model in Section 2. The estimation methods with the computational algorithm and bandwidth selection are developed in Section 3. We establish the asymptotic results for both nonparametric and parametric estimation methods in Section 4. In Section 5, we propose two hypothesis testing procedures for the presence of time- and exposure-varying effects. The finite-sample performance of the proposed estimators is examined via simulations in Section 6. The proposed methods are applied to the ACTG 244 data in Section 7, and concluding remarks are given in Section 8.
2. STATISTICAL MODELS
Consider a study that enrolls a random sample of n subjects with the follow-up through time τ. For subject i, suppose observations of the response process Yi(t) are sampled at time points , where ni is the number of observations from subject i, and i = 1, · · ·, n. The sampling times are often irregular and depend on covariates. In addition, some subjects may drop out of the study early. Let be the number of observations taken on the ith subject by time t, where I(·) is the indicator function. Let Ci be the end of follow-up time or censoring time, whichever occurs first. The responses for subject i can only be observed at the time points before Ci. Thus Ni(t) can be written as , where is the counting process of sampling times. Let Xi(t) and Ui(t) be the possibly time-dependent covariates for the ith subject. Suppose Ui(t) has support and that {Yi(·), Xi(·), Ui(·), Ni(·); i = 1, · · ·, n} are independent identically distributed (iid) random processes. We assume noninformative censoring time Ci in that and . Assume that is independent of Yi(t), conditional on Xi(t), Ui(t), and Ci ≥ t. The censoring time Ci is allowed to depend on Xi(·) and Ui(·).
Suppose that consists of three parts, each of dimension p1, p2, and p3, respectively, over the time interval [0, τ ]. Let Ui(t) be a covariate process that has the potential to modify the effects of X3i(t). We propose the generalized semiparametric regression model with varying coefficients:
| (1) |
for 0 ≤ t ≤ τ, where g(·) is a known link function, α(·) is a p1-dimensional vector of unspecified functions, β is a p2-dimensional vector of unknown parameters, and γ(Ui(t)) is a p3-dimensional vector of functions. The superscript T represents the transpose of a vector or matrix. The first component of X(t) is set to be 1, which codes a nonparametric baseline function. The function γ(u) represents the effect of X3i(t) at level u of the covariate Ui(t). Setting the first component of X3i(t) to 1 also allows nonparametric modeling of the covariate Ui(t).
The model has wide applications, for example, the adaptive treatment randomization problem studied by Qi et al. (2017), the treatment switching problem studied by Chen et al. (2013), and the nonlinear interactions between dose intensity and other covariates studied by Yin et al. (2008). Our previous work studied the version of model (1) that specified the right-most term parametrically, , where is a p3-dimensional vector of possibly nonlinear parametric functions defined on the range of Ui(·). The theoretical development for estimating the nonparametric component γ(u) is significantly challenging, because the nonparametric functions α(t) and γ(u) have different domains, yet the smoothing for α(t) and γ(u) cannot be totally separated, because γ(u) is a function of the time-varying covariate process Ui(t).
3. ESTIMATION PROCEDURES
Assume that α(t) and γ(u) are smooth so that their first and second derivatives , , , and exist. Consider the local linear approximation for α(t) in a neighbourhood of t0, , and the local linear approximation for γ(u) in a neighbourhood of u0,. Then for and , model (1) can be approximated by
| (2) |
where , . Here and thereafter, is the inverse function of g(·). By the approximation (2), at each t0 and u0, and for fixed β, we consider the estimating function:
| (3) |
where , , , K1(·) and K2(·) are kernel functions, and h = hn and b = bn are bandwidth parameters. Here Wi(t) = W (t, Xi(t), Ui(t)) is a nonnegative weight process associated with different time periods, which may potentially be used to improve estimation efficiency.
Let be the solution to for each t0 and u0. The first p1 + p3 components of are denoted by . Let . The profile least-squares estimator is the root to the estimating function:
| (4) |
where is the first p1 + p3 rows of , whose expression can be derived based on the identity as follows:
Here we take [t1, t2] as a subinterval of (0, τ ) to avoid the boundary problems.
Plugging in , we obtain the estimator for the nonparametric components . Let include the first p1 elements of and let be the vector including the elements of from p1 + 1 to p1 + p3. Thus,. Estimation of α(t0) by is inefficient because it only utilizes the local observations with for . A more efficient estimator for α(t0) at t0 can be obtained through aggregation without restricting . Similarly, a more efficient estimator of γ(u0) can be obtained through aggregating over t such that Ui(t) = u0. We propose the following estimators and for α(t0) and γ(u0), respectively:
| (5) |
Where , and is the number of points in the union . For the motivating example, Uj(t) = t − Sj; thus,. If it is difficult to find can also be estimated by .
Computational algorithm
The estimators , , and can be calculated through the iterative algorithm:
Set initial values and ;
For each jump point of {Ni(·), i = 1, · · ·, n}, say t, and u = Ui(t), the mth step estimate is the root of the estimating function (3), satisfying , where is the estimate of β at the (m − 1)th step;
The mth step estimate is the solution of (4), obtained after replacing with , which is the first p1 + p3 components of ;
Repeating Steps 2 and 3, and are updated at each iteration until convergence. The estimate is at convergence, and is at convergence.
The aggregated estimates and are obtained using (5).
Bandwidth Selection
Instead of selecting bandwidths for estimators by the leave-one-out cross-validation method suggested by Rice & Silverman (1991), we choose suitable bandwidths via the K-fold cross-validation procedure (Tian et al., 2005). Supposing that subjects are randomly divided into K groups, (D1, D2, · · ·, DK), the K-fold cross-validation optimal bandwidth is
| (6) |
where the kth prediction error is given by
or k = 1, · · ·, K, where , , and are estimated using the data excluding subjects in Dk. This procedure can be repeated a few times, say 10, and take the average of the resulting optimal bandwidths to increase the stability.
4. ASYMPTOTIC PROPERTIES
Let α0(t), β0, and γ0(u) be the true value of α(t), β, and γ(u) under model (1), respectively. Let and . Let be the conditional mean rate of the sampling times. Let and , where w(t, x, u) is the deterministic limit of W (t, x, u) in probability as n → ∞. For each t, fU (t, u) is the density function of Ui(t) at u. Define and , where for a vector a. Let and .
In the following, we state the asymptotic results of the estimators , and , together with the estimators of their asymptotic covariance matrices.
Theorem 1. Assume Condition A in the Appendix holds. Then as n → ∞, converges in distribution to a mean-zero normal distribution , where and .
The asymptotic variance of can be derived using the empirical counterparts of Aβ and Σβ. Specifically, we define , , and . Let , , and .
A consistent estimator of the matrix Aβ is given by and a consistent estimator of Σβ is given by .
Theorem 2. Assume Condition A in the Appendix holds. Then
where and where , and is a p1 × (p1+p3)matrix with for j = 1, …, p1 and k = j, and otherwise.
The covariance matrix can be consistently estimated by , where
Theorem 3. Assume Condition A in the Appendix holds. Let [u1, u2] be a subset of . Then
as , for where , and is a p3 × (p1+p3)matrix with for j = 1, …, p3 and k = j + p1, and otherwise.
The asymptotic covariance matrix can be consistently estimated by , where
Where , and nu is the number of points in .
Let and . The following theorem presents a weak convergence result for over .
Theorem 4. Under Condition A in the Appendix, uniformly for , where
The process Gn(u) converges weakly to a zero-mean Gaussian process on [u1, u2].
5. HYPOTHESIS TESTING FOR γ(u)
This section develops hypothesis testing procedures for . Let Γ(u) be the cumulative coefficient function. Let γk(u) be the kth component of γ(u) and Γk(u) be the kth component of Γ(u).
First, we develop testing procedures for the hypotheses for , versus for some u ∈ [u1, u2], or with strict inequality for some u ∈ [u1, u2]. The null hypothesis H10 implies that the effect γk(u) of the kth component of X3(t) is zero at any the exposure level u ∈ [u1, u2]. The alternative hypothesis H1a means that the effect is not zero for at least some the exposure level of u, while H1m suggests a positive effect for some u.
Consider the test process ,. Then ,. Let be the kth component of Γ0(u) and Q1(k)(u) the kth component of Q1(u). Under H10, Γ0(k)(u) = 0 for u ∈ [u1, u2]. We propose the supremum-type and integrated squared difference-type test statistics:
The test statistics Sa1 and Sa2 capture general departures H1a, while the test statistics Sm1 and Sm2 are sensitive to the monotone departures H1m.
By Theorem 4, Gn(u), u ∈ [u1, u2] converges weakly to a mean-zero Gaussian process with continuous sample paths on u ∈ [u1, u2]. Furthermore, the distribution of Gn(u), for u ∈ [u1, u2], can be approximated using the Gaussian multipliers resampling method based on , where are independent standard normal random variables, and the are obtained by replacing the unknown quantities in Hi(t) with their corresponding empirical counterparts.
Let Gn(k)(u) and be the kth components of Gn(u) and , respectively. Then the distribution of Q1(k)(u), u ∈ [u1, u2], can be approximated by the conditional distribution of , given the observed data sequence. Hence, the distributions of Sa1, Sa2, Sm1, and Sm2 under H10 can be approximated by the conditional distribution of , , , and , given the observed data sequence, respectively.
Next, we develop testing procedures for the hypotheses H20: γk(u) does not depend on u for u ∈ [u1, u2], versus H2a: γk(u) changes over u ∈ [u1, u2], or H2m: γk(u) increases with u ∈ [u1, u2]. The null hypothesis H20 implies that the effect γk(u) does not change with the exposure levels of u. The tests can be applied to test the alternative hypothesis that γk(u) decreases with u simply by replacing X3(t) with −X3(t). Let . Then
| (7) |
where R(u, Γ) = (u − u1)−1{Γ(u) − Γ(u1)} − (u2 − u1)−1{Γ(u2) − Γ(u1)} is a transformation of Γ(·). Let Q2(k)(u) and R(u, Γk) be the kth component of Q2(u) and R(u, Γ), respectively.
Under H20, R(u, Γk) = 0, the equation (7) motivates the test statistics:
where is a number (u1, u2) so that the denominator of Q2(k)(u) does not vanish. The can be chosen close to u1 to make use of available data and to ensure the tests to be consistent.
Using the Gaussian multiplier method, the distributions of Ta1, Ta2, Tm1, and Tm2 under H20
can be approximated by the conditional distributions of , , , and , given the observed data sequence, respectively.
The tests Ta1 and Ta2 capture general departures H2a, while the tests Tm1 and Tm2 are sensitive to the monotone departure H2m. Note that the derivative dR(u, Γ)/du = (u − a)−1[Γ(u) − (u − a)−1Γ(u)] ≥ 0 under H2m with strict inequality for at least some u ∈ [u1, u2]. This, plus the fact that R(u, Γ) is non-decreasing with R(b, Γ) = 0, lead to the results that the tests based on Tm1 and Tm2 are consistent against H2m, and the tests based on Ta1 and Ta2 are consistent against H2a.
6. SIMULATION STUDIES
We conducted a simulation study to assess the finite-sample performance of the proposed methods under the model with three popular link functions:
| (8) |
for 0 ≤ t ≤ τ with τ = 3.5, where the covariate X1i(t) = 0.05t + 0.1X2i + Vi(t) is time-dependent with Vi(t) a standard normal random variable, X2i is a Bernoulli random variable with success probability of 0.5, X3i is a uniform random variable on [−1, 1], and Si is uniform on [0, 1]. We consider α0(t) = 0.1 cos(t), , β = 0.4, and , where different values of θ1 and θ2 are used. For the identity link and the logarithm link, the error has a normal distribution with mean ϕi and variance 0.04, and ϕi is N (0, 0.04). For the logit link, Yi(t) has the Bernoulli distribution with the probability of success of E{Yi(t)|Xi, Si}. The observation times follow a Poisson process with the proportional mean rate model h(t|Xi, Si) = 2 exp(0.9X2i). The censoring times Ci are generated from a uniform distribution on [2.5, 8]. There are approximately 6 observations per subject in the interval [0, τ ], and about 25% subjects are censored.
We take the Epanechnikov kernel K(u) = 0.75(1 − u2)I(|u| ≤ 1) and a unit weight function Wi(t) = 1. We let t1 = h/2 and t2 = τ − h/2 in (4) to avoid larger variations on the boundaries. We consider the following settings for the values of (θ1, θ2) under model (8):
For the identity link function, I10: (θ1, θ2) = (0, 0), I11: (θ1, θ2) = (−0.02, 0), I12: (θ1, θ2) = (−0.04, 0), and I13: (θ1, θ2) = (−0.06, 0); I20: (θ1, θ2) = (−0.2, 0), I21: (θ1, θ2) = (0, −0.08), I22: (θ1, θ2) = (0, −0.12), and I23: (θ1, θ2) = (0, −0.16).
For the logarithm link function, E10: (θ1, θ2) = (0, 0), E11: (θ1, θ2) = (−0.03, 0), E12: (θ1, θ2) = (−0.04, 0), and E13: (θ1, θ2) = (−0.05, 0); E20: (θ1, θ2) = (−0.2, 0), E21: (θ1, θ2) = (0, −0.06), E22: (θ1, θ2) = (0, −0.08), and E23: (θ1, θ2) = (0, −0.1).
For the logit link function, L10: (θ1, θ2) = (0, 0), L11: (θ1, θ2) = (−0.15, 0), L12: (θ1, θ2) = (−0.2, 0), and L13: (θ1, θ2) = (−0.25, 0); L20: (θ1, θ2) = (−0.2, 0), L21: (θ1, θ2) = (0, −0.6), L22: (θ1, θ2) = (0, −0.9), and L23: (θ1, θ2) = (0, −1.2).
The performance of , , and at fixed points t and u is measured through the bias (Bias), the sample standard error of the estimators (SEE), the sample mean of the estimated standard errors (ESE), and the 95% empirical coverage probability (CP). The overall performance of the estimator is evaluated by the square root of the integrated mean square error , where N is the number of simulations and is the estimate of α(t) in the jth simulation, j = 1, · · ·, N. The summary measure RMSEγ is defined likewise.
Using the cross-validation procedure based on (6), an initial 10-fold cross-validation bandwidth selection in 10 runs yields bandwidths between 0.2 and 0.5 with the average close to 0.3. A larger sample size yields to smaller bandwidths. Table 1 summarizes the Bias, SEE, ESE, and CP of estimating β and RMSEs of estimating α(t) and γ(t) under model (8) for I21, E21, and L21 with sample sizes n = 200, 400, and 600, using the bandwidths (h, b) = (0.2, 0.2), (0.25, 0.25), and (0.3, 0.3). Each entry of the tables is calculated based on 1,000 repetitions. For all three link functions, Table 1 shows that the biases are small, the estimated errors are close to the empirical standard errors. The coverage probabilities show slight under-coverage for the bandwidths (h, b) = (0.2, 0.2) for n = 200, but closer to their 95% nominal level for n = 400 and 600. Larger bandwidths (h, b) = (0.25, 0.25) and (0.3, 0.3) have better performance in terms of the coverage probabilities. The estimation standard errors decrease as the sample size increases.
TABLE 1:
Summary of Bias, SEE, ESE, and CP for β, and RMSEs for α(t) and γ(u) under model (8) with the settings I21, E21, and L21 for sample sizes n = 200, 400, and 600, using the unit weight function, and bandwidths (h, b) = (0.2, 0.2), (0.25, 0.25), and (0.3, 0.3), based on 1,000 simulations.
| Setting | (θ1, θ2) | n | h | b | Bias | SEE | ESE | CP | RMSEα0 | RMSEα1 | RMSEγ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Identity link | |||||||||||
| I21 | (0, −0.08) | 200 | 0.2 | 0.2 | 0.0038 | 0.0592 | 0.0532 | 0.917 | 0.0421 | 0.0236 | 0.0405 |
| 0.25 | 0.25 | 0.0040 | 0.0591 | 0.0539 | 0.922 | 0.0412 | 0.0213 | 0.0378 | |||
| 0.3 | 0.3 | 0.0039 | 0.0591 | 0.0544 | 0.926 | 0.0408 | 0.0200 | 0.0363 | |||
| 400 | 0.2 | 0.2 | 0.0006 | 0.0408 | 0.0384 | 0.936 | 0.0286 | 0.0162 | 0.0281 | ||
| 0.25 | 0.25 | 0.0005 | 0.0408 | 0.0387 | 0.941 | 0.0280 | 0.0148 | 0.0264 | |||
| 0.3 | 0.3 | 0.0005 | 0.0406 | 0.0389 | 0.938 | 0.0276 | 0.0140 | 0.0255 | |||
| 600 | 0.2 | 0.2 | 0.0015 | 0.0326 | 0.0317 | 0.938 | 0.0236 | 0.0131 | 0.0230 | ||
| 0.25 | 0.25 | 0.0016 | 0.0326 | 0.0319 | 0.939 | 0.0231 | 0.0120 | 0.0217 | |||
| 0.3 | 0.3 | 0.0016 | 0.0326 | 0.0321 | 0.946 | 0.0229 | 0.0114 | 0.0209 | |||
| Logarithm link | |||||||||||
| E21 | (0, −0.06) | 200 | 0.2 | 0.2 | 0.0031 | 0.0457 | 0.0412 | 0.911 | 0.0366 | 0.0189 | 0.0307 |
| 0.25 | 0.25 | 0.0017 | 0.0443 | 0.0417 | 0.937 | 0.0352 | 0.0171 | 0.0283 | |||
| 0.3 | 0.3 | 0.0017 | 0.0435 | 0.0421 | 0.946 | 0.0346 | 0.0160 | 0.0267 | |||
| 400 | 0.2 | 0.2 | 0.0006 | 0.0313 | 0.0296 | 0.936 | 0.0247 | 0.0129 | 0.0211 | ||
| 0.25 | 0.25 | 0.0005 | 0.0313 | 0.0298 | 0.939 | 0.0241 | 0.0117 | 0.0198 | |||
| 0.3 | 0.3 | 0.0005 | 0.0311 | 0.0300 | 0.937 | 0.0237 | 0.0111 | 0.0190 | |||
| 600 | 0.2 | 0.2 | 0.0012 | 0.0251 | 0.0244 | 0.933 | 0.0203 | 0.0103 | 0.0172 | ||
| 0.25 | 0.25 | 0.0013 | 0.0251 | 0.0245 | 0.939 | 0.0199 | 0.0095 | 0.0162 | |||
| 0.3 | 0.3 | 0.0012 | 0.0251 | 0.0246 | 0.937 | 0.0197 | 0.0090 | 0.0155 | |||
| Logit link | |||||||||||
| L21 | (0, −0.6) | 200 | 0.2 | 0.2 | 0.0524 | 0.1936 | 0.1813 | 0.928 | 0.2221 | 0.2128 | 0.2770 |
| 0.25 | 0.25 | 0.0354 | 0.1840 | 0.1794 | 0.947 | 0.1987 | 0.1787 | 0.2362 | |||
| 0.3 | 0.3 | 0.0263 | 0.1806 | 0.1790 | 0.949 | 0.1871 | 0.1623 | 0.2142 | |||
| 400 | 0.2 | 0.2 | 0.0188 | 0.1394 | 0.1244 | 0.916 | 0.1474 | 0.1309 | 0.1775 | ||
| 0.25 | 0.25 | 0.0119 | 0.1366 | 0.1242 | 0.929 | 0.1366 | 0.1158 | 0.1572 | |||
| 0.3 | 0.3 | 0.0082 | 0.1356 | 0.1247 | 0.929 | 0.1308 | 0.1073 | 0.1446 | |||
| 600 | 0.2 | 0.2 | 0.0085 | 0.1028 | 0.1008 | 0.948 | 0.1146 | 0.1025 | 0.1418 | ||
| 0.25 | 0.25 | 0.0037 | 0.1016 | 0.1011 | 0.948 | 0.1068 | 0.0922 | 0.1268 | |||
| 0.3 | 0.3 | 0.0009 | 0.1019 | 0.1016 | 0.945 | 0.1026 | 0.0863 | 0.1175 | |||
Table 1 also shows the overall performance of the estimators for , and in terms of RMSEα0, RMSEα1, and RMSEγ. It is clear that different link functions yield different levels of RMSEs. But they decrease as the sample size increases. Figure 1 shows the pointwise results for α0(t), α1(t), and γ(u) under the settings I21, E21, and L21 for n = 600 with (h, b) = (0.3, 0.3). We can see that the local estimators are close to the true values and the ESE provides a good approximation for the SSE of the point estimates. The empirical coverage probabilities are reasonably close to the correct nominal level.
FIGURE 1:
Plots of Bias, SEE, ESE, and CP of , and under model (8) with the settings I21, E21, and L21 for n = 600, using the unit weight function, and bandwidths (h, b) = (0.3, 0.3), based on 1,000 simulations. The left panel is for , the middle panel is for , and the right panel is for . The solid line is for identity link function, the dashed line is for logarithm link function, and the dotted line is for logit link function.
Next, we examine the finite sample performance of the proposed tests for testing H10 : γ(u) = 0 and H20 : γ(u) does not depend on u. We take u1 = 0.15, u2 = 2.35, and . For n = 400 and n = 600 with (h, b) = (0.3, 0.3), the empirical sizes and the powers of the test statistics Sa1, Sa2, Sm1, and Sm2 for testing H10 are shown in Table 2 and those of the test statistics Ta1, Ta2, Tm1, and Tm2 for testing H20 are shown in Table 3. Our simulations show that for sample sizes n = 400 and 600, the empirical sizes are close to their nominal level 0.05 for the three link functions. The powers of the tests increase as the sample size increases. The powers of the tests also increase as the alternative models are increasingly different from the null models. The powers of the supremum-type tests are comparable to the powers of the integrated tests.
TABLE 2:
Empirical sizes and powers of the test statistics Sa1, Sa2, Sm1, and Sm2 for testing H10 at the nominal level 0.05 under model (8) for three different link functions with various settings for sample sizes n = 400 and 600, using the unit weight function, and bandwidths (h, b) = (0.3, 0.3), based on 1,000 Gaussian multiplier samples and 1,000 simulations.
|
n = 400 |
n = 600 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Setting | (θ1, θ2) | Test | Sa1 | Sa2 | Sm1 | Sm2 | Sa1 | Sa2 | Sm1 | Sm2 |
| Identity link | ||||||||||
| I10 | (0, 0) | Size | 0.052 | 0.051 | 0.055 | 0.065 | 0.065 | 0.070 | 0.059 | 0.066 |
| I11 | (−0.02, 0) | Power | 0.182 | 0.177 | 0.263 | 0.257 | 0.223 | 0.221 | 0.308 | 0.311 |
| I12 | (−0.04, 0) | 0.499 | 0.481 | 0.632 | 0.599 | 0.653 | 0.635 | 0.762 | 0.742 | |
| I13 | (−0.06, 0) | 0.822 | 0.813 | 0.894 | 0.882 | 0.938 | 0.930 | 0.963 | 0.960 | |
| Logarithm link | ||||||||||
| E10 | (0, 0) | Size | 0.054 | 0.052 | 0.057 | 0.066 | 0.066 | 0.070 | 0.058 | 0.065 |
| E11 | (−0.03, 0) | Power | 0.507 | 0.495 | 0.632 | 0.621 | 0.657 | 0.647 | 0.774 | 0.758 |
| E12 | (−0.04, 0) | 0.748 | 0.746 | 0.828 | 0.827 | 0.880 | 0.886 | 0.929 | 0.933 | |
| E13 | (−0.05, 0) | 0.906 | 0.900 | 0.956 | 0.951 | 0.971 | 0.971 | 0.986 | 0.986 | |
| Logit link | ||||||||||
| L10 | (0, 0) | Size | 0.048 | 0.053 | 0.053 | 0.059 | 0.051 | 0.053 | 0.058 | 0.058 |
| L11 | (−0.15, 0) | Power | 0.600 | 0.531 | 0.718 | 0.635 | 0.769 | 0.722 | 0.843 | 0.793 |
| L12 | (−0.2, 0) | 0.840 | 0.780 | 0.904 | 0.839 | 0.940 | 0.902 | 0.968 | 0.934 | |
| L13 | (−0.25, 0) | 0.951 | 0.925 | 0.973 | 0.946 | 0.994 | 0.983 | 0.996 | 0.986 | |
TABLE 3:
Empirical sizes and powers of the test statistics Ta1, Ta2, Tm1, and Tm2 for testing H20 at the nominal level 0.05 under model (8) for three different link functions with various settings for sample sizes n = 400 and 600, using the unit weight function, and bandwidths (h, b) = (0.3, 0.3), based on 1,000 Gaussian multiplier samples and 1,000 simulations.
|
n = 400 |
n = 600 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Setting | (θ1, θ2) | Test | Ta1 | Ta2 | Tm1 | Tm2 | Ta1 | Ta2 | Tm1 | Tm2 |
| Identity link | ||||||||||
| I20 | (−0.2, 0) | Size | 0.076 | 0.061 | 0.068 | 0.053 | 0.067 | 0.060 | 0.061 | 0.061 |
| I21 | (0, −0.08) | Power | 0.365 | 0.421 | 0.479 | 0.550 | 0.469 | 0.546 | 0.591 | 0.709 |
| I22 | (0, −0.12) | 0.615 | 0.701 | 0.720 | 0.844 | 0.774 | 0.862 | 0.859 | 0.939 | |
| I23 | (0, −0.16) | 0.846 | 0.921 | 0.912 | 0.966 | 0.957 | 0.984 | 0.985 | 0.995 | |
| Logarithm link | ||||||||||
| E20 | (−0.2, 0) | Size | 0.079 | 0.067 | 0.074 | 0.060 | 0.073 | 0.054 | 0.057 | 0.061 |
| E21 | (0, −0.06) | Power | 0.383 | 0.433 | 0.497 | 0.553 | 0.496 | 0.568 | 0.620 | 0.711 |
| E22 | (0, −0.08) | 0.573 | 0.628 | 0.662 | 0.765 | 0.714 | 0.802 | 0.808 | 0.894 | |
| E23 | (0, −0.1) | 0.728 | 0.833 | 0.831 | 0.919 | 0.883 | 0.943 | 0.933 | 0.975 | |
| Logit link | ||||||||||
| L20 | (−0.2, 0) | Size | 0.069 | 0.058 | 0.071 | 0.059 | 0.067 | 0.067 | 0.057 | 0.059 |
| L21 | (0, −0.6) | Power | 0.337 | 0.424 | 0.471 | 0.563 | 0.442 | 0.551 | 0.565 | 0.717 |
| L22 | (0, −0.9) | 0.636 | 0.743 | 0.743 | 0.852 | 0.782 | 0.881 | 0.872 | 0.931 | |
| L23 | (0, −1.2) | 0.838 | 0.912 | 0.924 | 0.957 | 0.941 | 0.983 | 0.974 | 0.996 | |
More discussions and additional simulation results for different models and bandwidths are given in Appendix B in the Web-based Supplementary Material.
7. REAL DATA APPLICATION
We apply the developed methods to the ACTG 244 randomized trial summarized in the Introduction. We recently analyzed the same data set using the version of the model with the exposure-varying covariate effects specified parametrically (Qi et al., 2017); here application of the nonparametric method is more defensible, given the lack of knowledge about the appropriateness of the selected parametric form. ACTG 244 enrolled HIV-infected patients receiving zidovudine (ZDV) monotherapy, and monitored them every eight weeks for occurrence of the 215 (T215Y/F) ZDV resistance mutation. Upon detection of the 215 mutation, a subject was randomized to either continue ZDV add ddI, or add both ddI and NVP. Of 289 enrolled participants, 5 were randomized but went off study before taking any medication, 284 were dispensed ZDV, and 57 developed T215Y/F during follow-up, of whom 49 were randomized to ZDV (n = 17), ZDV+ddI (n = 15), or ZDV+ddI+NVP (n = 17). Subsequent to an independent review by the Data Safety Monitoring Board, all subjects were offered randomization to either ZDV+ddI or ZDV+ddI+NVP with six months of new follow-up. An additional objective is to assess the effect of this randomization among subjects who had not yet acquired the 215 mutation at the time of this randomization, again studying whether the treatment effect depends on the time of treatment randomization/switching. At the time of the interim review 137 subjects were still taking ZDV and were randomized to ZDV+ddI (n = 69) or ZDV+ddI+NVP (n = 68). The data set includes 182 white, 84 black, and 23 hispanic and other races.
7.1. Analysis of the effects of switching treatments after drug-resistant virus was detected
Let Y (t) be the square root of CD4 count t years post–study entry, Z1 be Gender (1 if Female; 0 if Male), Z2 be Age at study entry in years, and Z3 and Z4 be indicator variables coding race (Z3 = 1 if white and 0 otherwise; Z4 = 1 if black and 0 otherwise). Let S1 be the time between the dates of study entry and the first randomization triggered by occurrence of the T215Y/F mutation, such that U1(t) = t − S1 is the follow-up time starting at the date of the first randomization. Let TA1(t) be the indicator of being randomized to ZDV and t > S1, TA2(t) be the indicator of being randomized to ZDV+ddI and t > S1, and TA3(t) be the indicator of being randomized to ZDV+ddI+NVP and t > S1. These indicator variables are zero prior to detection of the 215 mutation.
The analysis includes all n = 284 enrolled subjects dispensed ZDV monotherapy, right-censoring the 98 subjects who stopped taking ZDV prior to the interim review at the time of stopping ZDV. Moreover, for this analysis subjects who did not develop the 215 mutation and underwent the second randomization are right-censored at the time of the second randomization.
The following model is used for the analysis:
| (9) |
for t ∈ [0, τ ], where τ = 2.5 years. The average of 10 runs of 10-fold cross-validation yields h = 1.3 and b = 1.1. We find that the results are not overly sensitive to the choice of bandwidths. Table 4 shows the estimates of the time-constant parameters (first block of the table) for [t1, t2] = [0, 2.5], and Figure 2 shows the estimates of α0(t), γ1(u), γ2(u), and γ3(u) with 95% pointwise confidence intervals using the unit weight function.
TABLE 4:
Estimated effects of adaptive treatment randomizations in the ACTG 244 trial using the unit weight function.
| Effect | Parameter | Estimate | Standard deviation | 95% Confidence limits | P-value | |
|---|---|---|---|---|---|---|
| Treatment effects after the T215Y/F mutation under model (9) | ||||||
| (first randomization) | ||||||
| Gender | β1 | −0.8604 | 0.8330 | −2.4931 | 0.7723 | 0.3017 |
| Age | β2 | 0.5479 | 0.2620 | 0.0343 | 1.0614 | 0.0365 |
| Race | β3 | 5.1418 | 0.4468 | 4.2661 | 6.0175 | < 0.001 |
| β4 | 4.7831 | 0.5084 | 3.7866 | 5.7795 | < 0.001 | |
| Treatment effects before the T215Y/F mutation under model (10) | ||||||
| (second randomization) | ||||||
| Gender | β1 | −0.4558 | 0.7455 | −1.9170 | 1.0054 | 0.5409 |
| Age | β2 | 0.0417 | 0.2947 | −0.5358 | 0.6192 | 0.8874 |
| Race | β3 | 0.0026 | 1.2067 | −2.3624 | 2.3677 | 0.9983 |
| β4 | −0.8498 | 1.2824 | −3.3634 | 1.6637 | 0.5075 | |
FIGURE 2:

Estimated effects of switching treatments after drug-resistant virus was detected using the unit weight function based on the ACTG 244 data. (a) is the estimated baseline function with 95% pointwise confidence intervals; (b), (c), and (d) are estimated , k = 1, 2, 3 with 95% pointwise confidence intervals under model (9), using h = 1.3 and b = 1.1.
We conduct the hypothesis tests for testing H10 : γk(u) = 0 against H1a : γk(u) ≠ 0 and H1m : γk(u) ≥ 0. For testing H20 against H2a and H2m, the monotone alternatives for γ1(u) is decreasing, and for γ2(u) and γ3(u) are increasing. In the test statistics, we use the unit weight function, bandwidths (h, b) = (1.3, 1.1), [u1, u2] = [0.1, 2.0], and .
Table 5 reports on the observed P -values of the test statistics Sa1, Sa2, Sm1, and Sm2 for testing H10 and the test statistics Ta1, Ta2, Tm1, and Tm2 for testing H20, based on 1,000 Gaussian multiplier samples using the unit weight function.
TABLE 5:
Observed P -values of the test statistics Sa1, Sa2, Sm1, and Sm2 for testing H10 and the test statistics Ta1, Ta2, Tm1, and Tm2 for testing H20, based on 1,000 Gaussian multiplier samples using the unit weight function.
| H10 | H20 | |||||||
|---|---|---|---|---|---|---|---|---|
| Testing | Sa1 | Sa2 | Sm1 | Sm2 | Ta1 | Ta2 | Tm1 | Tm2 |
| Treatment effects after the T215Y/F mutation under model (9) | ||||||||
| (first randomization) | ||||||||
| γ1(·) | 0.342 | 0.516 | 0.676 | 0.676 | 0.110 | 0.046 | 0.054 | 0.010 |
| γ2(·) | 0.850 | 0.792 | 0.768 | 0.616 | 0.470 | 0.554 | 0.238 | 0.324 |
| γ3(·) | 0.638 | 0.566 | 0.998 | 0.722 | < 0.001 | 0.001 | < 0.001 | 0.002 |
| Treatment effects before the T215Y/F mutation under model (10) | ||||||||
| (second randomization) | ||||||||
| γ2(·) | 0.538 | 0.662 | 0.278 | 0.408 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
| γ3(·) | 0.014 | 0.048 | 0.006 | 0.040 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
The first block of Table 5 shows that CD4 cell counts decreases significantly after drug-resistant virus was detected for those continuing on ZDV monotherapy. CD4 cell counts increases significantly even after drug-resistant virus was detected for those switching to the combination therapy ZDV+ddI+NVP. While the combination therapy ZDV+ddI does not increase CD4 cell counts, it has some positive effects for not letting CD4 cell counts continue to decrease. In conclusion, switching to the combination therapies based on the T215Y mutation has positive benefits as compared to continuing with ZDV monotherapy ZDV even after drug-resistant virus was detected.
7.2. Analysis of the effects of switching treatments before drug-resistant virus was detected
Now we assess the effect of the randomization to ZDV+ddI versus ZDV+ddI+NVP among the 137 participants who had not developed the 215 mutation by the time of the interim review and were randomized. Let S2 be the time between the date of the interim review and the date of the second randomization, and let U2(t) = t − S2. Let TB2(t) be the indicator of randomization to ZDV+ddI and t > S2, and let TB3(t) be the indicator of randomization to ZDV+ddI+NVP and t > S2. Zeros for both variables TB2(t) = 0 and TB3(t) = 0 indicate that a subject is taking ZDV at time t before the interim review.
We analyze the data with the following model:
| (10) |
for t ∈ [0, 2.5]. The range of the observed values for U2i(t), t ∈ [0, 2.5], is [0, 0.70]. We choose h = 0.7 and b = 0.8 selected by 10-fold cross-validation.
The estimates of the parameters are shown using the unit weight function in the second block of Table 4, and the point and 95% confidence interval estimates of α0(t), γ2(u), and γ3(u) are presented in Figure 3. We conduct the hypothesis tests for testing H10 : γk(u) = 0 against H1a : γk(u) ≠ 0 and H1m : γk(u) ≥ 0. For testing H20, we consider the alternative H2m, where γ2(u) and γ3(u) are increasing with u. In the test statistics, we use the unit weight function, bandwidths (h, b) = (0.7, 0.8), [u1, u2] = [0.1, 0.7], and .
FIGURE 3:

Estimated effects of switching treatments before drug-resistant virus was detected using the unit weight function based on the ACTG 244 data. (a) is the estimated baseline function with 95% pointwise confidence intervals; (b) and (c) are estimated , k = 2, 3 with 95% pointwise confidence intervals under model (10), using h = 0.7 and b = 0.8.l
The observed P -values shown in the second block of Table 5 suggests that switching to the combination therapies ZDV+ddI and ZDV+ddI+NVP both improve CD4 counts for patients without having yet developed the T215Y drug resistance mutation.
8. CONCLUDING REMARKS
This article develops a generalized semiparametric varying-coefficient model for longitudinal data. Our approach flexibly models three types of covariate effects: constant effects, nonparametric time-varying effects, and covariate-varying effects, where the central contribution of this work is to extend the method of Qi et al. (2017) that modeled the covariate-varying effects parametrically to model these effects nonparametrically. The new model provides greater flexibility and robustness. The asymptotic results for the nonparametric and parametric estimators are established. We have developed hypothesis testing procedures for testing whether and how the covariate effects such as X3i(t) are modified by Ui(t).
We have conducted an extensive simulation study to examine the performances of the proposed estimation and hypothesis testing procedures. Additional simulation results for different models and bandwidths are placed in Web Appendix B. The simulation study suggests that the performance of the estimation procedure depends on the model, the number of repeated measurements on each subject, as well as the sample size. The convergence rate for the identity link function is the fastest, and the logit link function has the slowest convergence rate among the models we consider. The required computation time for each model for sample size 400 is about 5 hours for models under the identity link function and about 20 hours for models under the logarithm link function and logit link function running on the institution’s High Performance Computing Cluster.
The efficient selection of the weight function is also a very challenging problem that would depend on the link function and require the knowledge of the distribution of the error processes. In Web Appendix C, we discuss a two-stage procedure in the framework of marginal approaches to improve estimation efficiency through weight-function selection. We conducted a simulation study to investigate the two-stage estimation procedure for model (1) under three different error processes and found that the two-stage estimation improves efficiency over the estimation using the unit weight function. The two-stage estimation procedure and the additional simulation results for model (8) are presented in Web Appendix C. We have analyzed the ACTG 244 data using the two-stage estimation procedure. The estimation results for the effects of treatment switching presented in Web Appendix D are similar to the results using unit weight function but slightly smaller standard errors.
All the program codes produced for the simulation study and data analysis, the data set along with a detailed README file for the step-by-step instructions, is available as a part of the Web-based Supplementary Materials.
Supplementary Material
ACKNOWLEDGEMENTS
The authors thank the Editor, the Associate Editor, and two referees for their thoughtful comments that greatly improved this article. This research was partially supported by a grant from National Institute of Allergy and Infectious Diseases. The research of Yanqing Sun was partially supported by a National Science Foundation grant and the Reassignment of Duties fund provided by the University of North Carolina at Charlotte. The authors thank the AIDS Clinical Trials Group for providing the ACTG 244 data, in particular Ronald Bosch and Justin Ritz for preparing the data set, reviewing the manuscript, and helpful discussions. We also wish to thank the ACTG 244 study participants and study team, including the study chairs Douglas L. Mayers & Thomas C. Merigan. The project described was supported by grants from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH), and National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.
9. APPENDIX: PROOFS OF THEOREMS
Condition A.
-
(A.1)
The censoring time Ci is noninformative in the sense that and ; is independent of Yi(t) conditional on Xi(t), Ui(t), and Ci ≥ t; the censoring time Ci is allowed to depend on the left continuous covariate process Xi(·);
-
(A.2)
The processes Yi(t), Xi(t), and λi(t), 0 ≤ t ≤ τ, are bounded, and their total variations are bounded by a constant; E|Ni(t2) − Ni(t1)|2 ≤ L(t2 − t1) for 0 ≤ t1 ≤ t2 ≤ τ, where L > 0 is a constant; E|Ni(t + h) − Ni(t − h)|2+v = O(h), for some v > 0;
-
(A.3)
The kernel function K(·) is symmetric with compact support on [−1, 1] and Lipschitz continuous; Bandwidths ; h → 0; nh2 → ∞ and nh5 is bounded;
-
(A.4)
The function g−1(·) is monotone and twice differentiable;
-
(A.5)
α0(t), γ0(u), e11(t), and e12(t) are twice differentiable; (e11(t))−1 is bounded over 0 ≤ t ≤ τ ; the matrices A and Σ are positive definite;
-
(A.6)
The limit , and exist and are finite.
Next, we present technical lemmas to be used in the proofs of the main theorems. The proofs of these lemmas are placed in Web Appendix A in the Web-based Supplementary Material.
The following notations are used:, , and . Let the random function satisfy: ψ(t, y, x, u) is continuous on {(t, x, u)}, uniformly in for s > 2. Let ψi(t) = ψ(t, Yi(t), Xi(t), Ui(t)). The kernel-weighted average for two-dimensional smoothers is defined as:
Lemma 1. Under Condition A, we have .
Lemma 2. Let Θ and be compact sets in Rp and Rq, let Φn(θ, u) be random functions, and let Φ(θ, u) be a fixed function of . Let δ(u) be a fixed function of taking values in Θ. Assume that as n → ∞ and that for every ε > 0, we have for . Then for any sequence of estimators , with uniformly in , we have that as n → ∞, uniformly in .
Lemma 3. Under Condition A, we have that as n → ∞, ,
uniformly in t ∈ [t1, t2], u ∈ [u1, u2] and β in a neighbourhood of β0.
Lemma 4. Under Condition A, as , nh2 → ∞ and nh6 = Op(1), we have
| (A.1) |
uniformly in t0 ∈ [t1, t2] and u0 ∈ [u1, u2], where
Furthermore, , uniformly in t ∈ [t1, t2] and u ∈ [u1, u2].
Proof of Theorem 1.
By Lemma 1, Lemma 3, and application of the Glivenko-Cantelli theorem to the estimating function (4), we have that as n → ∞,
| (A.2) |
where β0 is the unique root of u(β). Then by Theorem 5.9 of van der Vaart (1998), as n → ∞.
By the Glivenko-Cantelli theorem and Lemma 3, we obtain that as n → ∞,
Now we show that converges in distribution to a normal distribution. By the Taylor expansion,
| (A.3) |
By Lemma 3 and Lemma 4,
| (A.4) |
Hence,
which converges in distribution to a normal distribution with variance . Hence, as n → ∞.
Proof of Theorem 2.
-
a
Since , we have that as n → ∞, uniform in t ∈ [0, τ ] and u ∈ [u1, u2] by Lemma 1 and Theorem 1. Then
-
b
Following the proof of Lemma 4, we obtain
Note that is zero for the first p1 components and is for the first p1 components. Then
| (A.5) |
By Lemma A.1 of Yin et al. (2008),
uniformly in t ∈ [t1, t2] and u ∈ [u1, u2]. The first term of (A.5) becomes
In addition, by applying Lemma 3 to the second term of (A.5), we have
where
Following the arguments of Lemma 2 of Sun (2010), we obtain that as n → ∞,
| (A.6) |
where .
Proof of Theorem 3.
Following the same argument as the proof of Theorem 2, we have that as n → ∞, uniformly in u ∈ [u1, u2], and . □
Proof of Theorem 4.
By Lemma 4,
Thus,
which converges weakly to a mean-zero Gaussian process by central limit theorem. □
Footnotes
SUPPLEMENTARY MATERIALS
The Web Appendices referenced in the manuscript are available with this paper at The Canadian Journal of Statistics website on the Wiley Online Library.
BIBLIOGRAPHY
- Chen Q, Zeng D, Ibrahim JG, Akacha M, & Schmidli H (2013). Estimating time-varying effects for overdispersed recurrent events data with treatment switching. Biometrika, 100, 339–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fan J, Huang T, & Li R (2007). Analysis of longitudinal data with semiparametric estimation of covariance function. Journal of American Statistical Association, 102, 632–641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fan J & Li R (2004). New estimation and model selection procedures for semiparametric modeling in longitudinal data analysis. Journal of the American Statistical Association, 99, 710–723. [Google Scholar]
- Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, & De Cock K (2006). The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. The Lancet, 368(9534), 505–510. [DOI] [PubMed] [Google Scholar]
- Hastie T & Tibshirani R (1993). Varying-coefficient models. Journal of the Royal Statistical Society. Series B (Methodological), 55, 757–796. [Google Scholar]
- Hu Z, Wang N, & Carroll RJ (2004). Profile-kernel versus backfitting in the partially linear models for longitudinal/clustered data. Biometrika, 91, 251–262. [Google Scholar]
- Japour AJ, Welles S, D’Aquila RT, Johnson VA, Richman DD, Coombs RW, Reichelderfer PS, Kahn JO, Crumpacker CS, & Kuritzkes DR (1995). Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. Journal of Infectious Diseases, 171, 1172–1179. [DOI] [PubMed] [Google Scholar]
- Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Blättler WA, Lambert JM, Chari RV, Lutz RJ, Wong WL, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, & Sliwkowski MX (2008). Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Research, 68, 9280–9290. [DOI] [PubMed] [Google Scholar]
- Lin DY & Ying Z (2001). Semiparametric and nonparametric regression analysis of longitudinal data (with discussion). Journal of the American Statistical Association, 96, 103–113. [Google Scholar]
- Martinussen T & Scheike TH (2001). Sampling adjusted analysis of dynamic additive regression models for longitudinal data. Scandinavian Journal of Statistics, 28, 303–323. [Google Scholar]
- Principi N, Marchisio P, DePasquale MP, Massironi E, Tornaghi R, & Vago T (1994). HIV-1 reverse transcriptase codon 215 mutation and clinical outcome in children treated with zidovudine. AIDS Research and Human Retroviruses, 10, 721–726. [DOI] [PubMed] [Google Scholar]
- Qi L, Sun Y, & Gilbert PB (2017). Generalized semiparametric varying-coefficient model for longitudinal data with applications to adaptive treatment randomizations. Biometrics, 73, 441–451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qu A & Li R (2006). Quadratic inference functions for varying-coefficient models with longitudinal data. Biometrics, 62, 379–391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rice JA & Silverman BW (1991). Estimating the mean and covariance structure nonparametrically when the data are curves. Journal of the Royal Statistical Society. Series B (Methodological), 10, 233–243. [Google Scholar]
- Sun Y (2010). Estimation of semiparametric regression model with longitudinal data. Lifetime Data Analysis, 16, 271–298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun Y, Sun L, & Zhou J (2013). Profile local linear estimation of generalized semiparametric regression model for longitudinal data. Lifetime Data Analysis, 19, 317–349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tian L, Zucker D, & Wei LJ (2005). On the Cox model with time-varying regression coefficients. Journal of the American Statistical Association, 100, 172–183. [Google Scholar]
- Wu H & Liang H (2004). Backfitting random varying-coefficient models with time-dependent smoothing covariates. Scandinavian Journal of Statistics, 31, 3–19. [Google Scholar]
- Yin G, Li H, & Zeng D (2008). Partially linear additive hazards regression with varying coefficients. Journal of the American Statistical Association, 103, 1200–1213. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

